{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:32:33Z","timestamp":1778157153996,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01056-7","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T04:03:15Z","timestamp":1680926595000},"page":"3751-3758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: a 29-year review"],"prefix":"10.1007","volume":"23","author":[{"given":"Hicham","family":"Titou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Bouhamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,8]]},"reference":[{"issue":"21","key":"1056_CR1","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Devesa SS, Anderson WF, et al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064\u201373.","journal-title":"Blood"},{"issue":"10","key":"1056_CR2","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768\u201385.","journal-title":"Blood"},{"issue":"7","key":"1056_CR3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/archderm.139.7.857","volume":"139","author":"YH Kim","year":"2003","unstructured":"Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol. 2003;139(7):857\u201366.","journal-title":"Arch Dermatol"},{"issue":"2","key":"1056_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jaad.2008.09.063","volume":"60","author":"G Sun","year":"2009","unstructured":"Sun G, Berthelot C, Li Y, et al. Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides. J Am Acad Dermatol. 2009;60(2):231\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1056_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaad.2014.10.019","volume":"72","author":"M Desai","year":"2015","unstructured":"Desai M, Liu S, Parker S. Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and Sezary syndrome in the southeastern United States: a single institution cohort. J Am Acad Dermatol. 2015;72(2):276\u201385.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1056_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07526.x","volume":"156","author":"D Nashan","year":"2007","unstructured":"Nashan D, Faulhaber D, St\u00e4nder S, Luger TA, Stadler R. Mycosis fungoides: a dermatological masquerader. Br J Dermatol. 2007;156(1):1\u201310.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1056_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.path.2014.02.003","volume":"7","author":"ME Mart\u00ednez-Escala","year":"2014","unstructured":"Mart\u00ednez-Escala ME, Gonz\u00e1lez BR, Guitart J. Mycosis fungoides variants. Surg Pathol Clin. 2014;7(2):169\u201389.","journal-title":"Surg Pathol Clin"},{"key":"1056_CR8","unstructured":"Swerdlow SH, Campo E, Harris NL, et al, eds. World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissue. Revised 4th edition. Lyon : IARC Press, 2017."},{"key":"1056_CR9","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","volume":"53","author":"N Pimpinelli","year":"2005","unstructured":"Pimpinelli N, Olsen EA, Santucci M, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005;53:1053\u201363.","journal-title":"J Am Acad Dermatol"},{"issue":"18","key":"1056_CR10","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","volume":"18","author":"R Talpur","year":"2012","unstructured":"Talpur R, Singh L, Daulat S, et al. Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009. Clin Cancer Res. 2012;18(18):5051\u201360.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1056_CR11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.jaad.2021.06.860","volume":"86","author":"KS Suh","year":"2022","unstructured":"Suh KS, Jang MS, Jung JH, Kwon DI, Seong SH, Lee KH, Park JB. Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: a 29-year review. J Am Acad Dermatol. 2022;86(6):1275\u201384. https:\/\/doi.org\/10.1016\/j.jaad.2021.06.860. (Epub 2021 Jun 29 PMID: 34197872).","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"1056_CR12","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/ijd.15561","volume":"60","author":"IJ Moon","year":"2021","unstructured":"Moon IJ, Lee KH, Choi JW, Lee WJ, Won CH, Chang S, Choi JH, Lee MW. Clinical characteristics and long-term outcomes of 97 Korean patients with mycosis fungoides. Int J Dermatol. 2021;60(12):1510\u20139. https:\/\/doi.org\/10.1111\/ijd.15561. (Epub 2021 May 15 PMID: 33991105).","journal-title":"Int J Dermatol"},{"key":"1056_CR13","doi-asserted-by":"publisher","unstructured":"Geller S, Lebowitz E, Pulitzer MP, Horwitz SM, Moskowitz AJ, Dusza S, Myskowski PL. Outcomes and prognostic factors in African American and black patients with mycosis fungoides\/S\u00e9zary syndrome: Retrospective analysis of 157 patients from a referral cancer center. J Am Acad Dermatol. 2020; 83(2):430\u2013439. https:\/\/doi.org\/10.1016\/j.jaad.2019.08.073. Epub 2019 Sep 6. PMID: 31499157; PMCID: PMC7058509.","DOI":"10.1016\/j.jaad.2019.08.073"},{"issue":"495\u2013497","key":"1056_CR14","volume":"140","author":"A Mourad","year":"2020","unstructured":"Mourad A, Gniadecki R. Overall survival in mycosis fungoides: a systematic review and meta-analysis. J Invest Dermatol. 2020;140(495\u2013497): e5.","journal-title":"J Invest Dermatol"},{"key":"1056_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1590\/abd1806-4841.20187106","volume":"93","author":"GM Amorim","year":"2018","unstructured":"Amorim GM, Niemeyer-Corbellini JP, Quintella DC, et al. Clinical and epidemiological profile of patients with early stage mycosis fungoides. An Bras Dermatol. 2018;93:546\u201352.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"1056_CR16","doi-asserted-by":"publisher","first-page":"e0038","DOI":"10.5041\/RMMJ.10172","volume":"5","author":"N Horesh","year":"2014","unstructured":"Horesh N, Horowitz NA. Does gender matter in non-Hodgkin lymphoma? differences in epidemiology, clinical behavior, and therapy. Rambam Maimonides Med J. 2014;5(4):e0038.","journal-title":"Rambam Maimonides Med J"},{"issue":"4","key":"1056_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/ijd.15865","volume":"61","author":"D Miyashiro","year":"2022","unstructured":"Miyashiro D, Sanches JA. Characteristics and outcomes of 727 patients with mycosis fungoides and S\u00e9zary syndrome from a Brazilian cohort. Int J Dermatol. 2022;61(4):442\u201354. https:\/\/doi.org\/10.1111\/ijd.15865. (Epub 2021 Aug 26 PMID: 34435672).","journal-title":"Int J Dermatol"},{"key":"1056_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jdv.15236","volume":"33","author":"E Lebowitz","year":"2019","unstructured":"Lebowitz E, Geller S, Flores E, et al. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sezary syndrome: a retrospective analysis of 174 patients. J Eur Acad Dermatol Venereol. 2019;33:108\u201314.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1056_CR19","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1002\/cncr.27627","volume":"118","author":"P Quaglino","year":"2012","unstructured":"Quaglino P, Pimpinelli N, Berti E, et al. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian group of cutaneous lymphomas. Cancer. 2012;118:5830\u20139.","journal-title":"Cancer"},{"issue":"6","key":"1056_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00403-017-1744-1","volume":"309","author":"I Wieser","year":"2017","unstructured":"Wieser I, Wang C, Alberti-Violetti S, Lyons G, Tran C, Talpur R, Duvic M. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides. Arch Dermatol Res. 2017;309(6):453\u20139. https:\/\/doi.org\/10.1007\/s00403-017-1744-1. (Epub 2017 May 17 PMID: 28516243).","journal-title":"Arch Dermatol Res"},{"issue":"47","key":"1056_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1067\/mjd.2002.124696","volume":"2002","author":"HS Zackheim","year":"2002","unstructured":"Zackheim HS, McCalmont TH. Mycosis fungoides: the great imitator. Am Acad Dermatol. 2002;2002(47):914\u20138.","journal-title":"Am Acad Dermatol"},{"key":"1056_CR22","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0889-8588(03)00115-1","volume":"17","author":"BR Smoller","year":"2003","unstructured":"Smoller BR, Santucci M, Wood GS, et al. Histopathology and genetics of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 2003;17:1277\u2013311.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"1056_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388.PMID:23162541;PMCID:PMC3498738","volume":"15","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;15(3):388. https:\/\/doi.org\/10.3389\/fmicb.2012.00388.PMID:23162541;PMCID:PMC3498738.","journal-title":"Front Microbiol"},{"key":"1056_CR24","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/archderm.136.12.1483","volume":"136","author":"O Dereure","year":"2000","unstructured":"Dereure O, Levi E, Kadin ME. T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol. 2000;136:1483\u20136.","journal-title":"Arch Dermatol"},{"issue":"8","key":"1056_CR25","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","volume":"42","author":"F Trautinger","year":"2006","unstructured":"Trautinger F, Knobler R, Willemze R, et al. EORTC consensus recommendations for the treatment of mycosis fungoides\/Sezary syndrome. Eur J Cancer. 2006;42(8):1014\u201330.","journal-title":"Eur J Cancer"},{"issue":"9","key":"1056_CR26","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1111\/ijd.12821","volume":"54","author":"A Korekawa","year":"2015","unstructured":"Korekawa A, Kaneko T, Nakajima K, et al. Mycosis fungoides bullosa associated with bullous pemphigoid. Int J Dermatol. 2015;54(9):e366\u20138.","journal-title":"Int J Dermatol"},{"issue":"4","key":"1056_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archderm.1971.04000220060011","volume":"104","author":"HH Roenigk Jr","year":"1971","unstructured":"Roenigk HH Jr, Castrovinci AJ. Mycosis fungoides bullosa. Arch Dermatol. 1971;104(4):402\u20136.","journal-title":"Arch Dermatol"},{"key":"1056_CR28","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1468-3083.2006.02060.x","volume":"21","author":"JS Lee","year":"2007","unstructured":"Lee JS, Yun SJ, Lee JB, et al. A case of hyperpigmented mycosis fungoides: a rare variant. J Eur Acad Dermatol Venereol. 2007;21:983.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1056_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jaad.2011.06.023","volume":"67","author":"L Pavlovsky","year":"2012","unstructured":"Pavlovsky L, Mimouni D, Amitay-Laish I, Feinmesser M, David M, Hodak E. Hyperpigmented mycosis fungoides: an unusual variant of cutaneous T-cell lymphoma with a frequent CD8+ phenotype. J Am Acad Dermatol. 2012;67:69.","journal-title":"J Am Acad Dermatol"},{"key":"1056_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jdermsci.2009.10.010","volume":"57","author":"SY Suzuki","year":"2010","unstructured":"Suzuki SY, Ito K, Ito M, Kawai K. Prognosis of 100 Japanese patients with mycosis fungoides and Sezary syndrome. J Dermatol Sci. 2010;57:37\u201343.","journal-title":"J Dermatol Sci"},{"key":"1056_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jdermsci.2013.04.020","volume":"71","author":"S Tobisawa","year":"2013","unstructured":"Tobisawa S, Honma M, Ishida-Yamamoto A, Sajio Y, Iizuka H. Prognostic factors in 105 Japanese cases of mycosis fungoides and Sezary syndrome: clusterin expression as a novel prognostic factor. J Dermatol Sci. 2013;71:160\u20136.","journal-title":"J Dermatol Sci"},{"key":"1056_CR32","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","volume":"28","author":"NS Agar","year":"2010","unstructured":"Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised international society for cutaneous lymphomas\/European organisation for research and treatment of cancer staging proposal. J Clin Oncol. 2010;28:4730\u20139.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01056-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:11:52Z","timestamp":1698783112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,8]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01056-7","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,8]]},"assertion":[{"value":"14 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Approved by the local ethics committee and followed the declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}